Specifica
Specifica, a Q2 Solutions company, is a prominent antibody discovery provider utilizing its proprietary Generation 3 antibody libraries and advanced next-generation sequencing (NGS) analysis platforms. Delivering highly diverse, developable, and natural human antibody leads with exceptional biophysical profiles, Specifica empowers biopharmaceutical partners to bypass traditional optimization bottlenecks.
